| Pharmaceutical active ingredients: |
| Hydrocodone TartrateSulfogaiacol |
| Available forms, composition and doses of Entuss Expectorant Liquid: |
| Liquid; Oral; Hydrocodone Tartrate; Sulfogaiacol |
| Entuss Expectorant Liquid medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R05CA09 - GuaiacolsulfonateR05DA03 - Hydrocodone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Shire |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
H-Tuss-D | Hydrocodone Tartrate; Pseudoephedrine Hydrochloride | Cypress Pharmaceutical |
| Tussgen | Hydrocodone Tartrate; Pseudoephedrine Hydrochloride | IVAX |
| Tyrodone | Hydrocodone Tartrate; Pseudoephedrine Hydrochloride | The Harvard Drug Group |
| Protuss-D | Hydrocodone Tartrate; Pseudoephedrine Hydrochloride; Sulfogaiacol | First Horizon Pharmaceutical |
| De-Chlor NX | Hydrocodone Tartrate; Sulfogaiacol | Cypress Pharmaceutical |
| Hydron EX | Hydrocodone Tartrate; Sulfogaiacol | Cypress Pharmaceutical |
| Hydron KGS | Hydrocodone Tartrate; Sulfogaiacol | Cypress Pharmaceutical |
| Hy-KXP | Hydrocodone Tartrate; Sulfogaiacol | Cypress Pharmaceutical |
| Marcof | Hydrocodone Tartrate; Sulfogaiacol | Marnel Pharmaceuticals |
| Protuss | Hydrocodone Tartrate; Sulfogaiacol | First Horizon Pharmaceutical |